RESUMEN
The syndrome of periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) is an autoinflammatory disorder of unknown aetiology. Tonsillectomy may cause a prompt resolution of the syndrome. The aim was to study the histologic and immunological aspects of the palatine tonsils in PFAPA, to help understand the pathophysiology of the syndrome. Tonsils from children with PFAPA (n = 11) and children with tonsillar hypertrophy (n = 16) were evaluated histologically after haematoxylin and eosin staining. The number of different cell types was identified immunohistochemically by cluster of differentiation (CD) markers: CD3 (T cells), CD4 (T helper cells), CD8 (cytotoxic T cells), CD15 (neutrophils), CD20 (B cells), CD45 (all leucocytes), CD57 (NK cells) and CD163 (monocytes and macrophages). Tonsils from children with PFAPA showed reactive lymphoid hyperplasia dominated by well-developed germinal centres with many tingible body macrophages. The histologic findings were unspecific, and a similar morphologic appearance was also found in the tonsils from controls. The number of CD8+ cells in germinal centres differed between children with PFAPA [median 9 cells (quartiles: 5, 15)] and controls [18 cells (12, 33) (P = 0.001)] and between children with PFAPA with (median 14 cells; 9, 16) and without (4 cells; 3, 8) aphthous stomatitis (P = 0.015). For the other cell types, no differences in germinal centres were found between children with PFAPA and controls. In conclusion, a lower number of CD8+ cells were found in germinal centres of tonsils in children with PFAPA compared to controls, which may be a feature linked to the aetiology of the syndrome.
Asunto(s)
Linfocitos T CD8-positivos/inmunología , Fiebre/inmunología , Centro Germinal/inmunología , Enfermedades Autoinflamatorias Hereditarias/inmunología , Linfadenitis/inmunología , Tonsila Palatina/inmunología , Faringitis/inmunología , Estomatitis Aftosa/inmunología , Linfocitos T CD4-Positivos/inmunología , Niño , Preescolar , Femenino , Centro Germinal/citología , Humanos , Células Asesinas Naturales/inmunología , Recuento de Linfocitos , Macrófagos/inmunología , Masculino , Monocitos/inmunología , Neutrófilos/inmunología , Tonsila Palatina/cirugía , Síndrome , TonsilectomíaRESUMEN
In these case reports, we investigated pandemic influenza 2009 vaccination of primary hypogammaglobulinaemic patients. Three combined variable immunodeficiency (CVID) patients and one X-linked agammaglobulinaemia (XLA) patient were vaccinated with the pandemic vaccine A/California/7/2009 (H1N1)-like split virus (X179a) adjuvanted with the oil-in-water emulsion AS03. Subsequently, serum and peripheral blood mononuclear cells were sampled and used to measure the haemagglutination inhibition (HI) and antibody-secreting cell (ASC) responses. In addition, the IFN-γ, IL-2 and TNF-α producing CD4(+) Th1-cell response was determined as these cytokines are important indicators of cell-mediated immunity. Two of the CVID patients responded to vaccination as determined by a >4-fold rise in HI antibodies. These subjects also had influenza-specific ASC numbers, which, albeit low, were higher than prevaccination levels. In addition, vaccination induced CD4(+) Th1-cell responses in both the XLA patient and the CVID patients, although the frequency of influenza-responsive cells varied amongst the patients. These results suggest that hypogammaglobulinaemia patients can mount a CD4(+) Th1 cell-mediated response to influenza vaccination and, additionally, that influenza vaccination of some hypogammaglobulinaemia patients can produce an influenza-specific humoral immune response. The findings should be confirmed in larger clinical studies.
Asunto(s)
Agammaglobulinemia/inmunología , Vacunas contra la Influenza/inmunología , Células TH1/inmunología , Vacunación/efectos adversos , Adyuvantes Inmunológicos/uso terapéutico , Adulto , Células Productoras de Anticuerpos/inmunología , Linfocitos B/inmunología , Ensayos Clínicos como Asunto , Femenino , Pruebas de Inhibición de Hemaglutinación , Humanos , Subtipo H1N1 del Virus de la Influenza A/inmunología , Vacunas contra la Influenza/efectos adversos , Gripe Humana/inmunología , Gripe Humana/prevención & control , Interferón gamma/inmunología , Interleucina-2/inmunología , Masculino , Persona de Mediana Edad , Pandemias , Linfocitos T/inmunología , Factor de Necrosis Tumoral alfa/inmunologíaRESUMEN
Human cytomegalovirus (HCMV) antigens in glioblastoma (GBM) present opportunities for personalised immunotherapy. However, their presence in GBM tissue is still under debate, and evidence of their impact on functional immune responses and prognosis is sparse. Here, we investigated the presence of pp65 (UL83) and immediate early 1 (IE-1) HCMV antigens in a cohort of Norwegian GBM patients (n = 177), using qPCR, immunohistochemistry, and serology. HCMV status was then used to investigate whether viral antigens influenced immune cell phenotype, infiltration, activation and patient survival. Pp65 and IE-1 were detected by qPCR in 23% and 43% of GBM patients, respectively. Furthermore, there was increased seropositivity in GBM patients relative to donors (79% vs. 48%, respectively; Logistic regression, OR = 4.05, 95%CI [1.807-9.114], P = 0.001, also when adjusted for age (OR = 2.84, 95%CI [1.110-7.275], P = 0.029). Tissue IE-1-positivity correlated with increased CD3+CD8+ T-cell infiltration (P < 0.0001), where CD8+ effector memory T (TEM) cells accounted for the majority of CD8+T cells compared with peripheral blood of HCMV+ patients (P < 0.0001), and HCMV+ (P < 0.001) and HCMV- (P < 0.001) donors. HLA-A2/B8-restricted HCMV-specific CD8+ T cells were more frequent in blood and tumor of HCMV+ GBM patients compared with seronegative patients, and donors irrespective of their serostatus. In biopsies, the HCMV-specific CD8+ TEM cells highly expressed CTLA-4 and PD-1 immune checkpoint protein markers compared with populations in peripheral blood (P < 0.001 and P < 0.0001), which expressed 3-fold greater levels of CD28 (P < 0.001 and P < 0.0001). These peripheral blood T cells correspondingly secreted higher levels of IFNγ in response to pp65 and IE-1 peptide stimulation (P < 0.001). Thus, despite apparent increased immunogenicity of HCMV compared with tumor antigens, the T cells were tolerised, and HCMV status did not impact patient survival (Log Rank3.53 HR = 0.85 95%CI [0.564-1.290], P = 0.45). Enhancing immune functionality in the tumor microenvironment thus may improve patient outcome.
RESUMEN
Human babesiosis is a rare but potentially life-threatening parasitic disease transmitted by ixodid ticks, and has not previously been reported in Norway. We report a case of severe babesiosis that occurred in Norway in 2007. The patient had previously undergone a splenectomy. He was frequently exposed to tick bites in an area endemic for bovine babesiosis in the west of Norway. The patient presented with severe haemolysis and multiorgan failure. Giemsa-stained blood smears revealed 30% parasitaemia with Babesia spp. He was treated with quinine in combination with clindamycin, apheresis, and supportive treatment with ventilatory support and haemofiltration, and made a complete recovery. This is the first case reported in Norway; however Babesia divergens seroprevalence in cattle in Norway is high, as is the risk of Ixodes ricinus tick bite in the general population. Babesiosis should be considered in the differential diagnosis of unexplained febrile haemolytic disease.
Asunto(s)
Babesiosis/diagnóstico , Babesia/aislamiento & purificación , Babesiosis/tratamiento farmacológico , Humanos , Masculino , Persona de Mediana Edad , NoruegaRESUMEN
We have developed a sensitive dot-immunobinding assay to demonstrate and characterize the functional activity of soluble Fc gamma receptors (FcR). Samples containing soluble FcR were immobilized on a nitrocellulose membrane. Immune complexes of horseradish peroxidase and rabbit IgG antibodies to horseradish peroxidase (HRP) were allowed to react with nitrocellulose-bound FcR, and the immune complexes were visualized by HRP developer. The intensity of the grey dots reflected the amount of immune complex bound. Binding of immune complexes to placental extract containing soluble FcR was inhibited completely by IgG and Fc fragments, but not by F(ab')2 fragments, IgA and IgM. The method was used to characterize the subclass specificity of solubilized placental FcR. Human Fc fragments, and intact IgG1 and IgG3 proteins inhibited the binding whereas preparations of F(ab')2, IgG2 and IgG4 did not. In conclusion, the dot-immunobinding assay described is a rapid and simple method for the demonstration and characterization of functionally active soluble FcR.
Asunto(s)
Immunoblotting/métodos , Receptores de IgG/análisis , Complejo Antígeno-Anticuerpo/análisis , Unión Competitiva , Femenino , Humanos , Placenta/inmunología , Embarazo , Sensibilidad y Especificidad , Solubilidad , Proteína Estafilocócica ARESUMEN
Extracts from myelinated and unmyelinated nerves, prepared using Tris-HCl buffer with EDTA and ME, contained functionally active receptors for the Fc region of IgG (FcR). This was evident from the results obtained in indirect haemagglutination and rosette inhibition assays. Using a monoclonal antibody, a functional active 40-kDa FcR was purified from the nerve extracts. The receptor was a single-chained glycoprotein with low affinity for native IgG, apparently belonging to the FcRII family. In addition, peripheral nerve extracts contain FcR not recognised by the monoclonal antibody.
Asunto(s)
Nervios Periféricos/análisis , Receptores Fc/aislamiento & purificación , Anticuerpos Monoclonales , Western Blotting , Cromatografía de Afinidad , Ácido Edético , Electroforesis en Gel de Poliacrilamida , Pruebas de Hemaglutinación , Humanos , Fragmentos de Inmunoglobulinas , Inmunoglobulina G/inmunología , Mercaptoetanol , Peso Molecular , Nervios Periféricos/inmunología , Receptores Fc/metabolismo , Formación de Roseta , SolubilidadRESUMEN
Nitric oxide synthase is demonstrated immunohistochemically in the cytosol, on granules, and on syncytiotrophoblasts membranes. The enzyme is also detected on placental villous stroma cells, and on endothelial cells. The histochemical staining method NADPH-diaphorase stains the syncytiotrophoblasts intensely, and stroma cells more weakly. Membranes of syncytiotrophoblasts immobilized on nitrocellulose paper are also stained by NADPH-diaphorase, and by antisera to nitric oxide synthase. Oxidases of sex steroid synthesis do, however, influence placental trophoblasts and there are discrepancies in the staining pattern of endothelial cells. Caution should therefore be exercised when using NADPH-diaphorase as a staining method for nitric oxide synthase in placenta.
Asunto(s)
Aminoácido Oxidorreductasas/análisis , Placenta/enzimología , Trofoblastos/enzimología , Gránulos Citoplasmáticos/enzimología , Citosol/enzimología , Endotelio Vascular/enzimología , Femenino , Histocitoquímica , Humanos , Immunoblotting , Inmunohistoquímica , NADPH Deshidrogenasa , Óxido Nítrico Sintasa , Placenta/irrigación sanguínea , EmbarazoRESUMEN
F(ab')2-fragments of a mouse monoclonal antibody (B1D6) reacting with placental receptors for the Fc part of IgG (FcR) were used as affinity reagents for the purification of an antigen from placental extract (PE). The antigen agglutinated ovine erythrocytes (E) sensitized with rabbit antibodies (A) (EA), but not E or E sensitized with F(ab')2-fragments. It reduced the EA rosette-formation with mononuclear cells and the binding of soluble immune complexes to placental tissue. The antigen bound to aggregated IgG and Fc-fragments of IgG, but not to native IgG or F(ab')2-fragments of IgG. The data indicate that the purified antigen possesses FcR activity with low affinity for IgG. SDS-PAGE and Western blot showed one distinct band of approximately 40 kD. The electrophoretic mobility did not change after reduction and the band reacted with concanavalin A indicating that the FcR are single-chained glycoproteins.
Asunto(s)
Antígenos de Diferenciación/aislamiento & purificación , Receptores Fc/aislamiento & purificación , Anticuerpos Monoclonales , Western Blotting , Cromatografía de Afinidad , Electroforesis en Gel de Poliacrilamida , Humanos , Inmunoglobulina G , Técnicas Inmunológicas , Proteínas Gestacionales/aislamiento & purificación , Receptores de IgGRESUMEN
We have previously produced a monoclonal antibody (mAb), B1D6, reactive with a 37 kD placental IgG Fc-binding molecule (FcR), recently identified as annexin II. Annexin II is an intracellular molecule found in several cell types, including endothelium and monocytes. Since soluble Fc-binding molecules are of importance in the regulation of the immune response, we have now used B1D6 in a competitive ELISA to study levels of soluble annexin II in human sera. Soluble annexin II was detected in all sera studied. The highest levels were observed in patients with infectious mononucleosis. Gel filtration of sera revealed annexin II in fractions corresponding to a molecular weight of 40-60 kD. In Western blot analysis a molecule of approximately 37 kD was found. The pI of soluble annexin II was about 7.5-8 as demonstrated by chromatofocusing. Annexin II belongs to a family of phospholipid-binding molecules involved in anti-inflammatory responses, and elevated levels of annexin II in serum may be important for the suppression of an immune response.
Asunto(s)
Anexina A2/sangre , Ensayo de Inmunoadsorción Enzimática , Receptores de IgG/análisis , Anexina A2/inmunología , Anticuerpos Monoclonales/inmunología , Artritis Reumatoide/sangre , Unión Competitiva , Western Blotting , Neoplasias del Ventrículo Cerebral/sangre , Cromatografía de Afinidad , Femenino , Pruebas de Hemaglutinación , Humanos , Immunoblotting , Mononucleosis Infecciosa/sangre , Cirrosis Hepática Biliar/sangre , Masculino , Placenta/inmunología , Embarazo , Receptores de IgG/inmunología , Formación de Roseta , Sensibilidad y EspecificidadRESUMEN
Annexin II (AII) is a member of a family of glycoproteins which bind negatively charged phospholipids in a calcium-dependent manner. Annexins are membrane-associated proteins, expressed both in normal and malignant cells, but have also been detected as soluble molecules in serum and other body fluids. Because of their adhesive properties, it has been suggested that annexins play a role in the metastatic process. An ELISA was established for quantification of soluble AII. Within-run variation was 5.2-10.4% and run-to-run variation 12.4-15.6%. Soluble AII was detected in all sera studies. A strongly positive serum was arbitrarily given the value 100 AII units and used as reference serum. The mean level in sera from 20 normal blood donors was 49 (SE 5.6) AII units. Sera from peripheral blood of five patients with renal cell carcinoma and sera from blood obtained from the renal vein of the same patients contained 47 (SE 20) and 83 (SE 28) AII units, respectively. In two patients, AII levels were increased in renal vein serum as compared with peripheral blood serum. Interestingly, in both cases, and in none of the three remaining cases, phytohaemagglutinin-stimulated lymphoproliferation was suppressed by renal vein serum as compared with peripheral blood serum. Affinity absorption of AII from the renal vein sera with increased AII levels strongly reduced their immunosuppressive activity. Addition of affinity-purified AII to cell cultures suppressed lymphoproliferation. These data show that the level of AII is markedly increased in renal vein sera from some patients with renal cell carcinoma, suggesting that AII may be locally released in vivo. The study also demonstrates an immunosuppressive effect of soluble AII in vitro. We speculate that soluble AII released by the tumour has immunosuppressive properties. This study identifies soluble AII as a novel immunosuppressive factor in sera from patients with renal cell carcinoma. A further study including a larger number of patients is currently in progress, in order to investigate the pathological significance of this finding.
Asunto(s)
Anexina A2/farmacología , Carcinoma de Células Renales/inmunología , Inmunosupresores/sangre , Neoplasias Renales/inmunología , Activación de Linfocitos/efectos de los fármacos , Fitohemaglutininas/farmacología , Anexina A2/sangre , Anexina A2/química , Humanos , Tolerancia InmunológicaRESUMEN
Extracts from psoriatic scales, prepared using Tris-HCl buffer containing ethylenediaminetetraacetatic acid (EDTA) and 2-mercaptoethanol (ME), agglutinated erythrocytes (E) sensitized with IgG antibodies (A) (EA), but not E or E sensitized with F(ab')2-fragments of IgG. The agglutination was inhibited by IgG and Fc fragments of IgG, but not by IgA, IgM or F(ab')2-fragments of IgG. Partially reduced and alkylated IgG did not inhibit the agglutination, indicating that an inter-heavy-chain disulphide-linked Fc region is required for binding of FcR. The extracts inhibited EA, but not E or EAC rosette formation with mononuclear cells. The results strongly indicated that the extract contained functionally active FcR. The agglutinating activity of the extract was not affected by treatment with periodic acid or formaldehyde, whereas heat reduced the activity. Using a monoclonal antibody (B1D6) a functionally active 40 kDa FcR with low affinity for native IgG was purified from the scale extract. The extracts also contained FcR activity not recognized by B1D6.
Asunto(s)
Antígenos de Diferenciación/análisis , Inmunoglobulina G , Psoriasis/inmunología , Receptores Fc/análisis , Western Blotting , Cromatografía de Afinidad , Electroforesis en Gel de Poliacrilamida , Humanos , Receptores de IgG , SolubilidadRESUMEN
OBJECTIVE: To determine immunity to tetanus in male blood donors with previous diphtheria-pertussis-tetanus (DPT)/tetanus toxoid (TT) vaccination. DESIGN: A cross sectional study, conducted in September 1999. SETTING: Blood bank, Muhimbili Medical Centre, Dar es Salaam, Tanzania. METHODS: Using an antigen competition ELISA technique, serum tetanus anti-toxin levels in two hundred male blood donors were determined. RESULTS: Vaccination history was absent in 43 (21.5%) blood donors, whereas 60 (30%) and 97 (48.5%) reported childhood DPT and TT vaccination, respectively. Tetanus anti-toxin was undetectable in 47 (23.5%) blood donors and the levels were below that considered protective (> or = 0.1 IU/ml) in 25 (12.5%). Among those with undetectable level, 43 (91.5%) had no vaccination history. Time after last DPT/TT vaccination correlated significantly with tetanus anti-toxin levels (r2=-0.331, p=0.001). In multivariate analysis, TT doses received and time after last vaccination explained 4.8% and 29.4%, respectively, of the variations in tetanus anti-toxin levels. CONCLUSION: Seventy two (36%) male blood donors were susceptible to tetanus and the susceptibility was highest from 48 years. A regular TT booster dose at 10 yearly intervals is recommended to provide adequate and long lasting immunity in male adults. Proper keeping of vaccination records is emphasised.
Asunto(s)
Vacuna contra Difteria, Tétanos y Tos Ferina/administración & dosificación , Tétanos/prevención & control , Adolescente , Adulto , Anciano , Donantes de Sangre , Vacuna contra Difteria, Tétanos y Tos Ferina/inmunología , Humanos , Esquemas de Inmunización , Masculino , Registros Médicos , Persona de Mediana Edad , Estudios Seroepidemiológicos , Tanzanía , Tétanos/inmunologíaRESUMEN
This study was conducted to investigate immunity to tetanus among pregnant women with verbal histories or documentation of having been vaccinated under the current five-dose tetanus toxoid (TT) schedule. It examined sera from 176 pregnant women attending antenatal care at Muhimbili Medical Centre in Dar es Salaam, Tanzania. Tetanus antitoxin level of 0.1 IU/ml was considered protective. Our findings show that 94.9% of women had tetanus antitoxin > or = 0.1 IU/ml. Multivariate analysis revealed that time after last vaccination, TT doses received and TT vaccination status explained 7.5%, 5.7% and 2.3% of variations in tetanus antitoxin levels respectively. Pregnant women with non-protective levels of tetanus antitoxin (5.1%) pose great risks of neonatal tetanus to their newborns and are also susceptible to maternal tetanus. Proper keeping of TT vaccination records is vitally important to avoid hyper-immunisation.
Asunto(s)
Embarazo/inmunología , Atención Prenatal , Toxoide Tetánico/administración & dosificación , Tétanos/prevención & control , Vacunación , Adolescente , Adulto , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Esquemas de Inmunización , Paridad , Embarazo/sangre , Tanzanía , Tétanos/transmisión , Antitoxina Tetánica/sangre , Toxoide Tetánico/inmunologíaAsunto(s)
Neuroborreliosis de Lyme/complicaciones , Síndrome de Opsoclonía-Mioclonía/diagnóstico , Síndrome de Opsoclonía-Mioclonía/microbiología , Adulto , Antibacterianos/administración & dosificación , Anticuerpos/sangre , Anticuerpos/líquido cefalorraquídeo , Ataxia/microbiología , Ataxia/fisiopatología , Borrelia burgdorferi/inmunología , Encéfalo/microbiología , Encéfalo/fisiopatología , Ceftriaxona/administración & dosificación , Femenino , Humanos , Neuroborreliosis de Lyme/diagnóstico , Neuroborreliosis de Lyme/fisiopatología , Imagen por Resonancia Magnética , Náusea/etiología , Dolor de Cuello/microbiología , Noruega , Síndrome de Opsoclonía-Mioclonía/fisiopatología , Tiempo , Tomografía Computarizada por Rayos X , Resultado del TratamientoAsunto(s)
Líquido Amniótico/química , Antígenos CD/análisis , Sangre Fetal/química , Lactante , Glicoproteínas de Membrana/análisis , Embarazo/sangre , Líquido Amniótico/inmunología , Antígenos CD/fisiología , Antígenos CD59 , Calostro/química , Calostro/inmunología , Complejo de Ataque a Membrana del Sistema Complemento/metabolismo , Femenino , Sangre Fetal/inmunología , Humanos , Recién Nacido , Glicoproteínas de Membrana/fisiología , Proteínas de la Leche/análisis , Proteínas de la Leche/inmunología , Leche Humana/química , Leche Humana/inmunología , Embarazo/inmunologíaAsunto(s)
Inmunidad Materno-Adquirida/inmunología , Inmunoglobulina M/metabolismo , Placenta/inmunología , Receptores Fc/metabolismo , Animales , Sitios de Unión , Transporte Biológico , Femenino , Humanos , Inmunidad Materno-Adquirida/fisiología , Intercambio Materno-Fetal/inmunología , Placenta/metabolismo , Embarazo , Receptores Fc/clasificaciónRESUMEN
S100A12 is a calcium-binding protein predominantly found in neutrophil granulocytes and monocytes. Its usefulness in monitoring inflammatory disease states depends on documentation that assay results are reliable. This study aimed at defining guidelines for blood sampling, selection of optimal material handling and reference intervals in healthy controls while taking into account the basic features of S100A12. An enzyme linked immunosorbent assay was developed based upon antibodies induced in rabbits by injection of recombinant S100A12. Our studies confirm that oligomers of S100A12 are generated in the presence of calcium. Structural changes in S100A12 mediated by calcium influence the interaction with antibody. This is proposed as the background for our very low readings of S100A12 in Ethylene Diamine Tetraacetic Acid (EDTA) plasma. Individual S100A12 levels did not change substantially over a 5-week sampling period. Based upon testing of 150 blood donors we suggest reference intervals of S100A12 in serum to be 49-1340 microg/l for women and 27-1750 microg/l for men. The estimated mean concentrations were 234 microg/l in serum samples (range 12-15791), 114 microg/l (range 3-17282) in re-calcified EDTA plasma and 48 microg/l (range 2-14843) in heparin plasma. Without adding calcium to EDTA plasma before running the assay, concentrations were around 2 microg/l (16 persons). S100A12 quantification is assumed to become relevant for diagnostic use in many disease states. The importance of the handling and analysing conditions for a reliable result was examined. We recommend serum collected in gel-containing tubes as the preferred sample material and have suggested reference intervals for healthy individuals.
Asunto(s)
Ensayo de Inmunoadsorción Enzimática , Proteínas S100/sangre , Adulto , Factores de Edad , Anciano , Métodos Analíticos de la Preparación de la Muestra , Calcio/química , Femenino , Heparina/química , Humanos , Masculino , Persona de Mediana Edad , Proteína S100A12 , Factores SexualesRESUMEN
Paroxysmal nocturnal haemoglobinuria (PNH) is a clonal stem cell disorder in which a defect of glycophosphatidylinositol (GPI)-anchored proteins leads to higher morbidity and mortality because of intravascular haemolysis, haemoglobinuria, pancytopenia and an increased frequency of thrombotic events. We report here the clinical features of a pregnant woman with PNH and present an immunhistochemical analysis of complement regulators, leukocyte activation markers and placental alkaline phosphatase (PALP) on syncytiotrophoblasts and inflammatory cells in her placenta. Placental tissue from normal deliveries served as controls. The patient had severe PNH with haemolysis, thrombosis episodes and signs of bone marrow failure. Placental syncytiotrophoblasts and villous cells of fetal origin in both normal placentas and the placenta from the PNH patient expressed PALP and the complement regulators CD46, CD55 and CD59. Additionally, CD11b-positive leukocytes of presumed maternal origin were negative for CD15 in the PNH placenta, while they stained positive within the villous space and in normal placentas. These findings show that fetally derived cells in the PNH placenta expressed GPI-linked molecules that are known to be of importance for a successful pregnancy outcome.
Asunto(s)
Glicosilfosfatidilinositoles/biosíntesis , Hemoglobinuria Paroxística/metabolismo , Placenta/metabolismo , Complicaciones Hematológicas del Embarazo/metabolismo , Fosfatasa Alcalina/metabolismo , Antígenos CD55/metabolismo , Antígenos CD59/metabolismo , Femenino , Citometría de Flujo , Hemoglobinuria Paroxística/enzimología , Hemoglobinuria Paroxística/inmunología , Humanos , Inmunohistoquímica , Masculino , Placenta/enzimología , Placenta/inmunología , Embarazo , Complicaciones Hematológicas del Embarazo/enzimología , Complicaciones Hematológicas del Embarazo/inmunologíaRESUMEN
Annexin II, a member of the annexin family of Ca2+ and phospholipid binding proteins, is present in human placenta. Placental annexin II has low affinity FcR activity, and is present as a heterotetramere on syncytiotrophoblast apical cell membrane extracellular surface. In addition to annexin II, transmembraneous leukocyte FcRIII is present on syncytiotrophoblast apical membrane. Either one, or both molecules may mediate the binding of IgG and thereby facilitate its transport through the syncytiotrophoblast layer. However, the presence of other maternal plasma proteins in syncytiotrophoblasts that are not transported to the human fetus is suggestive of nonspecific fluid phase endocytosis. The MHC class I like FcR, similar to the receptor found in neonatal rodent intestine, FcRn, is present intracellularly in human syncytiotrophoblasts, as is its light chain beta 2-microglobulin. The hFcRn is not detected on the apical plasma membrane. The placental hFcRn co-localizes with IgG in syncytiotrophoblast granules. It is likely that hFcRn binds and transcytoses IgG through the syncytiotrophoblast. Protected transfer of IgG may occur within syncytiotrophoblast endocytotic vesicles prior to release in the villous stroma and subsequent translocation into the lumen of fetal stem vessels by uptake and transport in endothelial caveolae.
Asunto(s)
Proteínas Portadoras/inmunología , Proteínas Portadoras/metabolismo , Inmunoglobulina G/metabolismo , Intercambio Materno-Fetal/inmunología , Proteínas Gestacionales/inmunología , Proteínas Gestacionales/metabolismo , Receptores de IgG/metabolismo , Animales , Femenino , Humanos , EmbarazoRESUMEN
The fetal syncytiotrophoblast cells in close contact with maternal blood circulation apparently lack surface expression of HLA molecules, including the HLA light chain beta 2-microglobulin. This is thought to contribute significantly to a successful pregnancy. We find that syncytiotrophoblasts do express beta 2-microglobulin. Beta 2-microglobulin is primarily localized intracellularly in apical granules, and co-localize with human IgG. The origin and function of syncytiotrophoblast beta 2-microglobulin is unknown, but its localization in the syncytiotrophoblasts may implicate beta 2-microglobulin in the transplacental transport of IgG in conjunction with a recently identified class I HLA-like receptor for IgG/Fc. Alternatively, beta 2-microglobulin may associate with a hitherto unidentified class I HLA molecule.